Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer
Table 1
Laboratory data of posttreatment day 14. Decline of leukocytes, neutrophils, and platelets. Elevation of C-reactive protein. A blood gas analysis did not show any abnormal data.